Deep Brain Stimulation Device Market Trends That Will Shape the Next Decade: Insights from Innovative Advancements In Deep Brain Stimulation Devices

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Deep Brain Stimulation Device Market Size By 2025?
The market size for deep brain stimulation devices has witnessed a quick expansion in recent years, escalating from $1.54 billion in 2024 to a projected $1.72 billion in 2025. This corresponds to a compound annual growth rate (CAGR) of 11.5%. Factors contributing to this growth during the historic period include a rising incidence of neurological disorders, an aging demographic, the limited effectiveness of medications, enhanced awareness and acceptance, and improved surgical procedures.

How Big Is the Deep Brain Stimulation Device Market Size Expected to Grow by 2029?
Expectations are high for the deep brain stimulation device market as it is anticipated to grow rapidly over the next few years. By 2029, it is projected to reach a market size of $2.67 billion with a compound annual growth rate (CAGR) of 11.7%. The expansion predicted during this forecast period is due in part to increasing uses for dbs, enhanced healthcare spending, development of progressive devices, greater patient receptiveness, government support and funding, and collaboration efforts. The period is also likely to see trends such as a more patient-focused design and user interface, increased research and development in closed-loop neuromodulation, the integration of telehealth, clarification of regulatory pathways, and increased collaboration and partnerships.

View the full report here:
https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-device-global-market-report

Which Key Market Drivers Powering Deep Brain Stimulation Device Market Expansion and Growth?
The deep brain stimulation device market is projected to expand due to the rising occurrence of neurological diseases. Neurological disorders refer to ailments that impact the central and peripheral nervous systems. Deep brain stimulation devices are utilized to regulate abnormal brain activity and correct chemical imbalances within the brain that results in various conditions. For instance, the World Health Organization, a specialized health agency based in Switzerland, reported in February 2023 that approximately 50 million people worldwide suffered from epilepsy. Furthermore, the Parkinson's Foundation report in 2022, a non-profit organization based in the US serving Parkinson's disease patients, indicated that there were 90,000 new cases of Parkinson's disease each year. This reflects a 50% rise from the initially anticipated rate of 60,000 diagnoses annually. Accordingly, the escalating prevalence of neurological disorders is fueling the growth of the deep brain stimulation device market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10733&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Deep Brain Stimulation Device Market?
In the deep brain stimulation device market, prominent companies are pioneering technological innovations, such as connected care technology. This technology is designed to elevate patient care by facilitating remote programming while bolstering communication standards between patients and health providers and optimizing the treatment results for people with movement disorders. Connected care technology encompasses the assimilation of digital tools and platforms that allow constant communication and data sharing between patients and healthcare providers, improving patient monitoring, management of treatment, and comprehensive healthcare service. For instance, in January 2024, Abbott Laboratories, a company headquartered in the US that specializes in healthcare and medical devices, obtained approval from the US Food and Drug Administration for their Liberta RC DBS system. This is the smallest rechargeable deep brain stimulation device intended for treating movement disorders. The Liberta RC DBS system's main features are its remote programming capabilities through the NeuroSphere Virtual Clinic, a requirement of merely 10 recharges annually, and a compact design that is 31% smaller than other competitive devices. The system also includes a wireless charging system capable of recharging the device every 37 days and provides adaptable controls via an Abbott patient controller or compatible iOS devices.

What Are the Emerging Segments in the Deep Brain Stimulation Device Market?
The deep brain stimulation device market covered in this report is segmented -

1) By Product Type: Single-Channel Deep Brain Stimulator, Dual-Channel Deep Brain Stimulator
2) By Application: Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Depression, Dystonia, Parkinson's Disease, Pain Management, Other Applications
3) By End User: Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers

Subsegments:
1) By Single-Channel Deep Brain Stimulator: Implantable Pulse Generators, Electrode Leads, Accessories
2) By Dual-Channel Deep Brain Stimulator: Implantable Pulse Generators, Electrode Leads, Accessories

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10733&type=smp

Who Are the Global Leaders in the Deep Brain Stimulation Device Market?
Major companies operating in the deep brain stimulation device market include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Functional Neuromodulation Ltd, NeuroPace, Inc., LivaNova PLC, Beijing PINS Medical Co. Ltd., SceneRay Corporation, Synapse Biomedical Inc., Deep Brain Innovation LLC, Nevro Corp., MicroPort NeuroTech, Stimwave LLC, Sapiens Neuro, Neuronetics Inc., BlueWind Medical Ltd., Brainsway Ltd., Neuralink Corporation, Med-Ally LLC, Axion BioSystems Inc., CereGate GmbH, NeuroSigma Inc., Bioinduction Ltd., Alpha Omega Engineering Ltd., Helius Medical Technologies, ANM Adaptive Neuromodulation GmbH, MagVenture A/S, Precisis AG, Monteris Medical Inc.

Which are the Top Profitable Regional Markets for the Deep Brain Stimulation Device Industry?
North America was the largest region in the deep brain stimulation devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global deep brain stimulation devices market report during the forecast period. The regions covered in the deep brain stimulation device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10733

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.